Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
€ 0
Key Takeaways
Risk factor
Very high price volatility
Data is available to registered users only
Data is available to registered users only
Profitability factor
Greatly undervalued vs peers
Data is available to registered users only
Data is available to registered users only
About
Paion AG is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies in the fields of anesthesia, intensive care, and critical care medicine, with a primary emphasis on short-acting sedatives and related hospital products.
Company Valuation
Based on key historical and expected multiples, the stock is greatly undervalued relative to its peers.
Data is available to registered users only
